Navigation Links
PMG Research Designated a Quintiles Prime Site

Winston-Salem, NC (PRWEB) August 13, 2014

PMG Research, Inc. announced today its designation as a Quintiles Prime Site. PMG Research provides clinical research services to large physician practices and integrated health systems, with access to 1.7 million patient lives. PMG Research is comprised of 10 hub site locations and spans 53 physician practices. PMG Research and Quintiles have been working together for 20 years to deliver clinical research solutions to the pharmaceutical industry.

The mission of PMG Research is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to its clinical trial partners and stakeholders. PMG Research, celebrating its 35th anniversary this year, has conducted over 7,100 trials for hundreds of pharmaceutical sponsors and CROs and has extensive experience conducting all phases of clinical research across a comprehensive list of conditions.

“We are incredibly proud to have been selected as a Quintiles Prime Site,” explains Jennifer Byrne, CEO of PMG Research. “Our broad therapeutic capabilities, strong regulatory track record, deeply engaged physician investigators, and continuously growing access to patients makes PMG Research a great fit for the Prime Site program. We look forward to taking what is already a highly collaborative relationship to the next level, building a transformational partnership that allows us to better achieve our mission: bringing clinical research to as many lives as possible.”

“The healthcare landscape is changing, and advances in science, analytics and therapeutic knowledge offer the promise of better treatments. The realization of this promise will only be possible by working differently, and our Prime Site program is an example of this,” explains Lindy Jones, Head of Integrated Patient & Site Strategies, Quintiles. "We are proud to be working with the team at PMG Research with whom we already have a track record of success having worked together on over 300 studies which have enrolled over 3200 patients. With the enthusiasm and vision for this model that our PMG Research Care partner has shown, we are confident that this will serve as a strong foundation for future collaboration as we strive to improve our customers’ probability of success.”

About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit

About Quintiles
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 30,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
(Date:11/24/2015)...  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... and chief executive officer, will present at the 27 th ... New York City . The presentation will be ... at 9:30 a.m. EST. and go ... least 15 minutes prior to the presentation to allow for ...
(Date:11/24/2015)... ... ... Whitehouse Laboratories is pleased to announce that it has completed construction on ... to basic USP 61, USP 62 and USP 51 testing specific to raw materials ... micro testing performed by one supplier. Management has formally announced that the ...
(Date:11/23/2015)... Women with a certain type of lung nodule ... risk of lung cancer than men with similar nodules, according ... annual meeting of the Radiological Society of North ... --> Lung nodules are small masses of tissue ... based on their appearance on CT. Solid nodules are dense, ...
(Date:11/23/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the second quarter and first half ... --> --> Second Quarter ... second quarter of fiscal 2016 increased by 12.7% to ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
(Date:10/29/2015)... , October 29, 2015 ... authentication company focused on the growing mobile commerce ... announces that StackCommerce, a leading marketplace to discover ... the Wocket® smart wallet on StackSocial for this ... ("NXT-ID" or the "Company"), a biometric authentication company ...
Breaking Biology News(10 mins):